June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Visualizing Relative Blood Flow Speeds in Choroidal Neovascularization Using Variable Interscan Time Analysis (VISTA-) Optical Coherence Tomography Angiography (OCTA)
Author Affiliations & Notes
  • Carl B Rebhun
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Eric M. Moult
    Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Boston, Massachusetts, United States
    Research Laboratory of Electronics, Massachusetts Institute of Technology, Boston, Massachusetts, United States
  • Stefan B. Ploner
    Pattern Recognition Lab, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • Fareed Rifai
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
    University of South Alabama School of Medicine, Mobile, Alabama, United States
  • Carlos Moreira
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
    Federal University of Sao Paulo, Sao Paulo, Brazil
  • A. Yasin Alibhai
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Julia Schottenhamml
    Pattern Recognition Lab, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • ByungKun Lee
    Research Laboratory of Electronics, Massachusetts Institute of Technology, Boston, Massachusetts, United States
    Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Boston, Massachusetts, United States
  • Caroline R Baumal
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Philip J Rosenfeld
    Bascom Palmer Eye Institute of University of Miami Leonard M. Miller School of Medicine, Miami, Florida, United States
  • Jay S Duker
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • James G Fujimoto
    Research Laboratory of Electronics, Massachusetts Institute of Technology, Boston, Massachusetts, United States
    Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Boston, Massachusetts, United States
  • Nadia Waheed
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Carl Rebhun, None; Eric Moult, None; Stefan Ploner, None; Fareed Rifai, None; Carlos Moreira, None; A. Yasin Alibhai, None; Julia Schottenhamml, None; ByungKun Lee, None; Caroline Baumal, Allergan (C), Genentech (C); Philip Rosenfeld, Carl Zeiss Meditec (R), Carl Zeiss Meditec (F), Carl Zeiss Meditec (C); Jay Duker, Carl Zeiss Meditec (F), Carl Zeiss Meditec (C), Optovue (F), Optovue (C), Topcon (F), Topcon (C); James Fujimoto, Carl Zeiss Meditec (P), Optovue (I), Optovue (P); Nadia Waheed, Carl Zeiss Meditec (R), Genentech (C), Janssen (C), Macula Vision Research Foundation (F), Nidek (R), Ocudyne (C), Optovue (R), Regeneron (C)
  • Footnotes
    Support  National Institute of Health 5-R01-EY011289-28; Air Force Office of Scientific Research FA9550-15-1-0473, FA9550-10-1-0551; Macula Vision Research Foundation Grant
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 818. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Carl B Rebhun, Eric M. Moult, Stefan B. Ploner, Fareed Rifai, Carlos Moreira, A. Yasin Alibhai, Julia Schottenhamml, ByungKun Lee, Caroline R Baumal, Philip J Rosenfeld, Jay S Duker, James G Fujimoto, Nadia Waheed; Visualizing Relative Blood Flow Speeds in Choroidal Neovascularization Using Variable Interscan Time Analysis (VISTA-) Optical Coherence Tomography Angiography (OCTA). Invest. Ophthalmol. Vis. Sci. 2017;58(8):818.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recent advances in optical coherence tomography angiography (OCTA) provide insight into the natural history of choroidal neovascularization (CNV) secondary to neovascular age related macular degeneration (nAMD). Visualizing relative blood flow speeds longitudinally within CNV may provide valuable additional information regarding the evolution of CNV and their response to vascular endothelial growth factor (VEGF) inhibitors.

Methods : OCTA imaging of patients with CNV secondary to nAMD was performed using a 400kHz, 1050nm swept source OCT system with a 5 repeated B-scan protocol. Variable interscan time analysis (VISTA) was used to compute relative flow speeds from pairs of B-scans having 1.5 ms and 3.0 ms separations, which were then mapped to a color space for display.

Results : Seven eyes of 6 subjects (4 women and 2 men) with nAMD were evaluated. Prior to initial imaging, 6 of 7 eyes received anti-VEGF injections, while 1 eye was treatment naïve (Figure 1). CNV in all eyes at each visit showed relatively higher flow speed in the trunk vessels and lower flow speed at the periphery. Changes in the extent and distribution of high and low speed vessels was observed as anti-VEGF treatment continued, with some low speed vessels near the central trunk becoming larger in diameter and acquiring high flow speed characteristics.

Conclusions : Longitudinal follow-up of CNV secondary to nAMD demonstrated increased flow speed in the main trunk vessels and decreased flow speed in the smaller vessels, generally at the periphery of the lesion. Changes in flow characteristics were observed after anti-VEGF treatment. Visualization of relative blood flow speeds with VISTA-OCTA in CNV may be useful for developing quantitative clinical endpoints.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

A) OCTA-VISTA of treatment naïve CNV. B) OCTA-VISTA 1 month after first treatment with anti-VEGF. Note faster flow in central trunk vessels (white arrowheads) and slower flow in the periphery (pink asterisks). In VISTA-OCTA images, blue corresponds to slower blood flow and red to faster blood flow.

A) OCTA-VISTA of treatment naïve CNV. B) OCTA-VISTA 1 month after first treatment with anti-VEGF. Note faster flow in central trunk vessels (white arrowheads) and slower flow in the periphery (pink asterisks). In VISTA-OCTA images, blue corresponds to slower blood flow and red to faster blood flow.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×